Optimized Expansion of the Implanted Transcatheter Aortic Valve | MicrobiomeTrials← Back to trialsNCT07042529
Optimized Expansion of the Implanted Transcatheter Aortic Valve
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2025-10-05Est. Completion: 2029-07-01
Enrollment target: 1,010 participants Locations- AZORG ziekenhuis, Aalst, Belgium
- CHU Charleroi, Charleroi, Belgium
- UZ Leuven, Leuven, Belgium
- AZ Delta, Roeselare, Belgium
- Skejby Hospital, Aa, Denmark
- Aalborg University Hospital, Aalborg, Denmark
- Rigshospitalet, Copenhagen, Denmark
- Odense University Hospital, Odense C, Denmark
- Turku University Hospital, Turku, Finland
- UMC Amsterdam, Amsterdam, Netherlands
- University Medical Center Groningen, Groningen, Netherlands
- Leiden University Medical Center, Leiden, Netherlands
- St. Antonius Hospital, Nieuwegein, Netherlands
- Haukeland hospital, Haukeland, Norway
- Oslo universitetssygehus, Oslo, Norway
- Sahlgrenska University Hospital, Gothenburg, Sweden
- Skånes universitetssjukhus, Skåne, Sweden
Other microbiome trials you might be interested in
Mesenteric Vascular DiseaseColorectal SurgeryPreventive Intervention
Rationale:
Anastomotic leakage (AL) is a severe complication of colon surgery, with an incidence of 2.7-11.9%. It is as…
Emmen, NetherlandsEst. completion Feb 1, 2028
Aortic Valve InsufficiencyAortic Valve Stenosis
The objective of this study is to establish the safety and effectiveness of the Edwards SAPIEN X4/X4S Transcatheter Hear…
Newport Beach, United StatesEst. completion Mar 2029
Background:
Researchers are testing version of a system known as a magnetic resonance imagining (MRI) scanner that uses…
Bethesda, United StatesEst. completion May 31, 2028